Riskpilot← Back to searchSign inGet full accessFJORDENLEGENE AS
ASActiveOrg 996484378St Halvards Vei 15, 3186 HortenGeneral medical practice activities · NACE 8621Est. 20113 employees
Revenue 2024
NOK 4,5M
+49% vs 2023
EBITDA margin
-15.5%
-235% vs 2023
Equity ratio
-28.4%
Financial strength
Net profit 2024
NOK -550K
-235% vs 2023
| Revenue | NOK 4,5M | +49% |
| EBITDA | NOK -703K | -235% |
| Net profit | NOK -550K | -235% |
| Total assets | NOK 777K | -2% |
| Equity | NOK -221K | -167% |
| Employees | 3 | — |
Legal name
FJORDENLEGENE AS
Org number
996484378
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. februar 2011
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulenttjenester for legetjenester, helsetjenester, rådgivning og veiledning hva gjelder behandling, eiendomsforvaltning og annet som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg, eller på annen måte gjøre seg interessert i andre foretak.
Address
St Halvards Vei 15, 3186 Horten
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 167 | 705 | 841 | 3 055 | 4 549 |
| Staff expenses | −0 | −0 | −0 | −1 613 | −4 066 |
| EBITDA | 110 | 682 | 818 | 520 | −703 |
| Depreciation & amort. | −7 | −7 | −7 | −0 | −0 |
| EBIT | 103 | 675 | 811 | 520 | −703 |
| Net financials | 0 | 0 | 0 | 1 | −1 |
| Profit before tax | 103 | 675 | 811 | 521 | −704 |
| Tax | 25 | 149 | 179 | 115 | −154 |
| Net profit | 78 | 527 | 633 | 406 | −550 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 615 | 556 | 1 164 | 790 | 777 |
| Equity | 114 | 490 | 123 | 329 | −221 |
| Long-term debt | 129 | 0 | 0 | 0 | 0 |
| Short-term debt | 373 | 65 | 1 041 | 460 | 997 |
| Total debt | 502 | 65 | 1 041 | 460 | 997 |
EBITDA margin
-15.5%
This company
15.8%
Market median
-198% vs market
20202024
Equity ratio
-28.4%
This company
38.2%
Market median
-174% vs market
20202024
Return on equity
-55022100.0%
This company
18.4%
Market median
-299033252% vs market
20202024
Net profit margin
-12.1%
This company
8.1%
Market median
-249% vs market
20202024
Asset turnover
5.86×
This company
1.12×
Market median
+423% vs market
20202024
Debt / equity
4.52×
This company
0.62×
Market median
-629% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Chairman | 2015 | |
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FJORDENLEGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Lehmann El-Safadi | Deputy Chairman | 0 companies |
| Badboni El-Safadi | Chairman | 0 companies |